Website
N/ATelephone
61.8.0036.7728
Address
Unit 3 11-13 Milgate Street Oakleigh South, Victoria (VIC) 3167
Description
dorsaVi Ltd. is a biotechnology company, which focuses on developing motion analysis device technologies for use in clinical practice, elite sports, and occupational health and safety. Its products include ViSafe, ViMove and ViPerform. The firm operates through the Clinical and Workplace segments. The company was founded by Daniel Matthew Ronchi and Andrew James Ronchi on February 18, 2008 and is headquartered in Oakleigh South, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.02
Trade Value (12mth)
AU$572.00
1 week
-8.33%
1 month
0%
YTD
0%
1 year
-8.33%
All time high
0.539533
EPS 3 yr Growth
-88.100%
EBITDA Margin
-124.90%
Operating Cashflow
-$1m
Free Cash Flow Return
-65.00%
ROIC
-122.30%
Interest Coverage
-9.10
Quick Ratio
2.00
Shares on Issue (Fully Dilluted)
538m
HALO Sector
Industrials
Next Company Report Date
28-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
dorsaVi secures commitments for $500k Placement
×
dorsaVi secures commitments for $500k Placement |
31 October 23 |
Proposed issue of securities - DVL
×
Proposed issue of securities - DVL |
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 23 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
31 October 17 |
Annual Report to shareholders
×
Annual Report to shareholders |
31 May 23 |
Cleansing Notice
×
Cleansing Notice |
31 May 23 |
Application for quotation of securities - DVL
×
Application for quotation of securities - DVL |
31 May 22 |
Notification of cessation of securities - DVL
×
Notification of cessation of securities - DVL |
31 January 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 January 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 August 22 |
Appendix 4E and Annual Report
×
Appendix 4E and Annual Report |
31 August 22 |
DVL 2022 Results Announcement
×
DVL 2022 Results Announcement |
31 August 22 |
Corporate Governance Statement and Appendix 4G
×
Corporate Governance Statement and Appendix 4G |
31 August 22 |
Appendix 3Y
×
Appendix 3Y |
31 August 22 |
Appendix 3Y
×
Appendix 3Y |
31 August 22 |
Appendix 3Y
×
Appendix 3Y |
31 August 22 |
Appendix 3Y
×
Appendix 3Y |
30 September 20 |
Annual General Meeting
×
Annual General Meeting |
30 September 15 |
Date of Annual General Meeting
×
Date of Annual General Meeting |
30 October 23 |
2023 AGM - Letter to Shareholders & Proxy Form
×
2023 AGM - Letter to Shareholders & Proxy Form |
30 October 23 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 November 23 |
DVL 2023 AGM Presentation
×
DVL 2023 AGM Presentation |
30 November 23 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
30 January 17 |
CEO Investor Presentation
×
CEO Investor Presentation |
29 November 16 |
AGM Address by Chairman and CEO Presentation
×
AGM Address by Chairman and CEO Presentation |
29 July 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
29 July 22 |
dorsaVi Announces Capital Raising
×
dorsaVi Announces Capital Raising |
29 July 22 |
Proposed issue of securities - DVL
×
Proposed issue of securities - DVL |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.